A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)

NCT06137183 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
79
Enrollment
INDUSTRY
Sponsor class

Stopped Based on a futility analysis, which suggested that the Moonglow study was unlikely to meet its primary endpoint.

Conditions

Interventions

Sponsor

Genentech, Inc.